Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Continuous Monitoring of Filling Line Performance – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Continuous Monitoring of Filling Line Performance – V 2.0

Standard Operating Procedure for Continuous Monitoring of Filling Line Performance


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/140/2025
Supersedes SOP/SIM/140/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To define the procedure for continuous monitoring of filling line performance in sterile injectable manufacturing, enabling detection of process inefficiencies, equipment issues, and variations in product quality in real time, ensuring adherence to

GMP standards and operational excellence.

2. Scope

This SOP is applicable to all sterile injectable filling lines within the manufacturing facility. It covers the monitoring of line speed, filling accuracy, reject rate, equipment alarms, line stoppages, and key process metrics during routine production operations.

3. Responsibilities

  • Machine Operators: Continuously monitor HMI screens, fill volumes, and alert supervisors of any anomalies.
  • Production Supervisors: Analyze real-time data and implement minor corrections. Maintain production logs.
  • Quality Assurance (QA): Review process parameters and deviations. Conduct spot checks.
  • Engineering: Maintain SCADA systems, handle alarms, calibrate sensors, and conduct diagnostics.
See also  Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intramuscular Injections - V 2.0

4. Accountability

The Production Manager is accountable for ensuring that real-time filling line monitoring is operational, documented, and integrated with corrective action protocols.

5. Procedure

5.1 System Requirements

  1. Ensure SCADA/HMI/PLC systems are operational and calibrated before initiating the batch.
  2. Confirm all sensors and indicators (e.g., fill weight, temperature, volume sensors) are functioning.

5.2 Monitoring Parameters

  1. Parameters to monitor:
    • Line speed (vials/minute or syringes/minute)
    • Fill weight or volume per unit
    • Rejection rate (%)
    • Downtime and cause
    • Number of interventions

5.3 Real-Time Display and Alerts

  1. Monitor all data through HMI or SCADA displays mounted on the filling line.
  2. Configure alerts for:
    • Fill volume deviation beyond ±2%
    • Reject rate >3%
    • Unexpected line stoppage >2 minutes
  3. Log each alert in the Performance Monitoring Log (Annexure-1).
See also  Sterile Injectable Manufacturing: SOP for Functional Testing of Prefilled Syringes - V 2.0

5.4 Documentation

  1. Fill in hourly performance log:
    • Output per hour
    • Cumulative rejects
    • Line downtime duration
  2. Attach printouts from SCADA systems for record-keeping.
  3. Highlight anomalies and record actions taken.

5.5 Reconciliation and Review

  1. At batch end, calculate:
    • Total units filled
    • Total rejects
    • Yield percentage
  2. QA to review the logs, SCADA reports, and investigate any trend shifts or repeated issues.

5.6 Corrective and Preventive Action (CAPA)

  1. If reject trends exceed target limits, initiate CAPA.
  2. Include maintenance checks, training refreshers, or review of operating SOPs if necessary.

5.7 Handling Alarms and Stoppages

  1. Operators must record all alarms and stoppages in the SCADA alarm summary log.
  2. Post-intervention checks must be verified by QA before restarting the line.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • SCADA: Supervisory Control and Data Acquisition
  • HMI: Human-Machine Interface
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Performance Monitoring Log – Annexure-1
  2. Alarm Summary Log – Annexure-2
  3. SCADA Summary Report – Annexure-3
See also  Sterile Injectable Manufacturing: SOP for Sampling Procedures during Manufacturing - V 2.0

8. References

  • WHO GMP Guidelines
  • ICH Q8 – Pharmaceutical Development
  • 21 CFR Part 11 – Electronic Records and Signatures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Performance Monitoring Log

Time Units Produced Rejects Downtime (min) Remarks
10:00–11:00 1800 30 0 Normal
11:00–12:00 1750 42 5 Sensor misalignment

Annexure-2: Alarm Summary Log

Time Alarm Description Resolved By Action Taken
11:15 Volume Low Filler nozzle clogged Arjun Patel Cleaned and flushed

Annexure-3: SCADA Summary Report

Time Fill Volume (mL) Speed (units/min) Reject %
10:00 5.02 90 1.6%
11:00 4.96 88 2.4%

Revision History

Revision Date Revision No. Details Reason Approved By
01/09/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 SCADA integration and alarm response updates Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Undefined Abbreviations and Acronyms in SOPs: A Risk to GMP Documentation Clarity
Next Post: SOPs vs Batch Records: What Goes Where?

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version